Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Reading Between the Lines: What PROMs Reveal About Itch
When Itching Hurts: Quality of Life Disruption in CKD-aP
CKD-aP Uncovered Prevalence & Pathophysiology
Spotlight on Assessment: Tools That Capture CKD-aP
What You Don’t See: A Patient’s View of Living with CKD-aP
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Jörg Latus, MD
Sayna Norouzi, MD
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Small Ball Wins Games – Combination Therapy for Goal Attainment
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Turning the Double Play – Comprehensive Secondary Prevention
ASCVD Playbook | Closing the Gaps, One Inning at a Time
Swing for the Fences – LDL-C as the Power Hitter
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Cracking the Code of Obstruction: Unmet Needs in oHCM
Michael Nassif, MD, MSc